Tyvaso



Indications and Reactions:

Role Indications Reactions
Primary
Pulmonary Arterial Hypertension 56.5%
Cor Pulmonale Chronic 24.0%
Pulmonary Hypertension 13.0%
Product Used For Unknown Indication 1.4%
Hypertension 1.2%
Systemic Sclerosis 0.8%
Primary Pulmonary Hypertension 0.5%
Cor Pulmonale 0.4%
Portal Hypertension 0.3%
Essential Hypertension 0.3%
Pulmonary Hypertension Secondary 0.3%
Chronic Obstructive Pulmonary Disease 0.2%
Chronic Pulmonary Heart Disease 0.2%
Sarcoidosis 0.2%
Scleroderma 0.2%
Atrial Septal Defect 0.1%
Back Pain 0.1%
Hepatic Cirrhosis 0.1%
Ph Body Fluid 0.1%
Portopulmonary Hypertension 0.1%
Death 35.4%
Pneumonia 12.8%
Dyspnoea 9.7%
Pulmonary Arterial Hypertension 5.0%
Syncope 4.4%
Fluid Retention 4.0%
Pulmonary Hypertension 3.6%
Cardiac Failure Congestive 3.5%
Fluid Overload 2.4%
Chest Pain 2.1%
Hypotension 1.9%
Oedema 1.8%
Epistaxis 1.7%
Oxygen Saturation Decreased 1.7%
Pulmonary Oedema 1.7%
Respiratory Failure 1.7%
Cerebrovascular Accident 1.6%
Cough 1.6%
Myocardial Infarction 1.6%
Bronchitis 1.5%
Secondary
Pulmonary Arterial Hypertension 44.9%
Product Used For Unknown Indication 15.5%
Pulmonary Hypertension 15.5%
Cor Pulmonale Chronic 6.7%
Chronic Obstructive Pulmonary Disease 4.0%
Cardiac Disorder 1.7%
Sleep Apnoea Syndrome 1.7%
Gastrooesophageal Reflux Disease 1.2%
Rheumatoid Arthritis 1.2%
Scleroderma 1.2%
Atrial Septal Defect 1.0%
Blood Pressure 0.7%
Left Ventricular Failure 0.7%
Pain 0.7%
Anxiety 0.5%
Bipolar Disorder 0.5%
Connective Tissue Disorder 0.5%
Drug Abuse 0.5%
Hypertension 0.5%
Hypothyroidism 0.5%
Pulmonary Arterial Hypertension 11.5%
Pneumonia 9.6%
Dyspnoea 8.7%
Death 6.7%
Cough 5.8%
Dizziness 4.8%
Epistaxis 4.8%
Lung Disorder 4.8%
Syncope 4.8%
Throat Irritation 4.8%
Transfusion 4.8%
Vomiting 4.8%
Pulmonary Hypertension 3.8%
Cardiac Failure Congestive 2.9%
Fluid Retention 2.9%
Hypotension 2.9%
Hypoxia 2.9%
Myocardial Infarction 2.9%
Nasal Congestion 2.9%
Oedema Peripheral 2.9%
Concomitant
Pulmonary Arterial Hypertension 43.6%
Product Used For Unknown Indication 25.6%
Pulmonary Hypertension 16.6%
Cor Pulmonale Chronic 3.0%
Scleroderma 2.5%
Connective Tissue Disorder 1.2%
Heart Disease Congenital 1.2%
Portopulmonary Hypertension 1.1%
Systemic Lupus Erythematosus 0.7%
Chronic Obstructive Pulmonary Disease 0.6%
Sleep Apnoea Syndrome 0.6%
Hypertension 0.5%
Interstitial Lung Disease 0.5%
Unevaluable Event 0.5%
Hiv Infection 0.4%
Rheumatoid Arthritis 0.3%
Atrial Septal Defect 0.3%
Diuretic Therapy 0.3%
Drug Abuse 0.3%
Hypoxia 0.3%
Death 21.5%
Pneumonia 13.5%
Syncope 9.8%
Dyspnoea 6.8%
Pulmonary Arterial Hypertension 6.4%
Cough 4.5%
Vomiting 4.5%
Pulmonary Hypertension 3.7%
Urinary Tract Infection 3.1%
Fluid Retention 2.7%
Myocardial Infarction 2.7%
Pyrexia 2.7%
Transfusion 2.7%
Pulmonary Oedema 2.5%
Unevaluable Event 2.5%
Heart Rate Increased 2.3%
Oedema 2.3%
Haemorrhage 2.0%
Oedema Peripheral 2.0%
Systemic Lupus Erythematosus 2.0%